Skip to content

Veracyte VCYT Net margin

Net margin at other companies

Guardant Health logo
Guardant HealthGH
-40.1%-8.1pp
Natera, Inc. logo
Natera, Inc.NTRA
-14.6%+0.6pp
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
6.5%+3.4pp
Revvity logo
RevvityRVTY
8.3%-2.1pp
Labcorp Holdings logo
Labcorp HoldingsLH
6.7%+1.1pp
Quest Diagnostics logo
Quest DiagnosticsDGX
9.1%+0.2pp

Other financials

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
Net income$28.7M+307%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation

See full
Market cap$4.28B+10.7%
Enterprise value$4.05B+7.4%
P/E48.6×-68.3×
P/S7.9×-0.4×

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0.0×
Current ratio9.3×+4.2×

Where this comes from

Calculated from Veracyte’s reported figures.

Based on trailing twelve months.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Veracyte's net margin?
Veracyte (VCYT) reported net margin of 16.2% in Q1 2026.
How has Veracyte's net margin changed year-over-year?
Veracyte's net margin increased by 127.8% year-over-year, from 7.1% to 16.2%.
What is the long-term trend for Veracyte's net margin?
Over 5 years (2020 to 2025), Veracyte's net margin has grown at a -15.5% compound annual growth rate (CAGR), from -29.7% to 12.8%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.